Cutaneous Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Cutaneous Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: A Non-drug Study Profiling Cutaneous Lupus
A completed non-drug clinical trial profiling cutaneous lupus and related lupus forms including cutaneous, systemic, and discoid lupus eryth…
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion [Phase 3]
Phase 3 trial evaluating hydroxychloroquine sulfate for efficacy and safety in patients with systemic lupus erythematosus or cutaneous lupus…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of fumaric acid esters (Fumaderm) for treating cutaneous lupus erythematosus has complete…
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus [Phase 1]
A multiple-dose Phase 1 study of Pfizer's PD-0360324 in patients with active Cutaneous Lupus Erythematosus was terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus [Phase 1]
A Phase 1 safety study of AMG 557 in subjects with subacute cutaneous lupus erythematosus was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)
The Interdisciplinary Study Group of Lupus Erythematosus (ISGLE) trial focusing on Cutaneous Lupus Erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus [Phase 2]
A Phase 2 clinical trial evaluating vitamin D status, disease-specific outcomes, and quality of life in patients with cutaneous lupus erythe…
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus [NA]
A completed Northwestern University trial evaluated the effectiveness of a knowledge-based intervention for patients with Cutaneous Lupus Er…
-
CLINICAL_TRIALS trial_result · 2012-10-08Clinical Trial Update: A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus [Phase 1]
Phase 1 safety and pharmacokinetic study of CNTO 136 in patients with cutaneous lupus erythematosus and systemic lupus erythematosus; the tr…
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus [Phase 4]
A Phase 4 clinical trial evaluating the safety and efficacy of lenalidomide for refractory cutaneous lupus has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-25Clinical Trial Update: Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser [Phase 2]
Phase 2 trial evaluating a 595 nm flashlamp pulsed dye laser for Cutaneous Lupus Erythematosus has completed.
-
FDA approval · 2008-02-20FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for hydroxychloroquine sulfate submitted by Teva Pharmaceuticals USA, Inc. The action represents an …
-
CLINICAL_TRIALS trial_result · 2007-09-10Clinical Trial Update: Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE) [Phase 2]
Phase 2 trial reports efficacy data for topical tacrolimus across different subtypes of cutaneous lupus erythematosus.
-
FDA approval · 2007-06-14FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Ipca Laboratories Limited)
FDA approved Ipca Laboratories Limited's original application for hydroxychloroquine sulfate as a generic product.
-
CLINICAL_TRIALS trial_result · 2007-05-08Clinical Trial Update: Sunscreen RV 2457C in Photoinduced CLE [Phase 3]
A Phase 3 trial evaluating Sunscreen RV 2457C for photoinduced Cutaneous lupus erythematosus has completed.